Global Pulmonary Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pulmonary Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pulmonary Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pulmonary Drugs by Country/Region, 2017, 2022 & 2028

2.2 Pulmonary Drugs Segment by Type

2.2.1 Inhaled Corticosteroids

2.2.2 Long Acting Beta-2 Agonists

2.2.3 Antihistamines

2.2.4 Vasodilators

2.2.5 Others

2.3 Pulmonary Drugs Sales by Type

2.3.1 Global Pulmonary Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Pulmonary Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pulmonary Drugs Sale Price by Type (2017-2022)

2.4 Pulmonary Drugs Segment by Application

2.4.1 Asthma & COPD

2.4.2 Allergic Rhinitis

2.4.3 Pulmonary Arterial Hypertension

2.4.4 Cystic Fibrosis

2.4.5 Others

2.5 Pulmonary Drugs Sales by Application

2.5.1 Global Pulmonary Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Pulmonary Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pulmonary Drugs Sale Price by Application (2017-2022)

3 Global Pulmonary Drugs by Company

3.1 Global Pulmonary Drugs Breakdown Data by Company

3.1.1 Global Pulmonary Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Pulmonary Drugs Sales Market Share by Company (2020-2022)

3.2 Global Pulmonary Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Pulmonary Drugs Revenue by Company (2020-2022)

3.2.2 Global Pulmonary Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Pulmonary Drugs Sale Price by Company

3.4 Key Manufacturers Pulmonary Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pulmonary Drugs Product Location Distribution

3.4.2 Players Pulmonary Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pulmonary Drugs by Geographic Region

4.1 World Historic Pulmonary Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Pulmonary Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pulmonary Drugs Annual Revenue by Geographic Region

4.2 World Historic Pulmonary Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Pulmonary Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pulmonary Drugs Annual Revenue by Country/Region

4.3 Americas Pulmonary Drugs Sales Growth

4.4 APAC Pulmonary Drugs Sales Growth

4.5 Europe Pulmonary Drugs Sales Growth

4.6 Middle East & Africa Pulmonary Drugs Sales Growth

5 Americas

5.1 Americas Pulmonary Drugs Sales by Country

5.1.1 Americas Pulmonary Drugs Sales by Country (2017-2022)

5.1.2 Americas Pulmonary Drugs Revenue by Country (2017-2022)

5.2 Americas Pulmonary Drugs Sales by Type

5.3 Americas Pulmonary Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pulmonary Drugs Sales by Region

6.1.1 APAC Pulmonary Drugs Sales by Region (2017-2022)

6.1.2 APAC Pulmonary Drugs Revenue by Region (2017-2022)

6.2 APAC Pulmonary Drugs Sales by Type

6.3 APAC Pulmonary Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pulmonary Drugs by Country

7.1.1 Europe Pulmonary Drugs Sales by Country (2017-2022)

7.1.2 Europe Pulmonary Drugs Revenue by Country (2017-2022)

7.2 Europe Pulmonary Drugs Sales by Type

7.3 Europe Pulmonary Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pulmonary Drugs by Country

8.1.1 Middle East & Africa Pulmonary Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pulmonary Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Pulmonary Drugs Sales by Type

8.3 Middle East & Africa Pulmonary Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pulmonary Drugs

10.3 Manufacturing Process Analysis of Pulmonary Drugs

10.4 Industry Chain Structure of Pulmonary Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pulmonary Drugs Distributors

11.3 Pulmonary Drugs Customer

12 World Forecast Review for Pulmonary Drugs by Geographic Region

12.1 Global Pulmonary Drugs Market Size Forecast by Region

12.1.1 Global Pulmonary Drugs Forecast by Region (2023-2028)

12.1.2 Global Pulmonary Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pulmonary Drugs Forecast by Type

12.7 Global Pulmonary Drugs Forecast by Application

13 Key Players Analysis

13.1 Sanofi SA

13.1.1 Sanofi SA Company Information

13.1.2 Sanofi SA Pulmonary Drugs Product Offered

13.1.3 Sanofi SA Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi SA Main Business Overview

13.1.5 Sanofi SA Latest Developments

13.2 Meda Pharmaceuticals

13.2.1 Meda Pharmaceuticals Company Information

13.2.2 Meda Pharmaceuticals Pulmonary Drugs Product Offered

13.2.3 Meda Pharmaceuticals Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Meda Pharmaceuticals Main Business Overview

13.2.5 Meda Pharmaceuticals Latest Developments

13.3 Circassia Pharmaceuticals Plc.

13.3.1 Circassia Pharmaceuticals Plc. Company Information

13.3.2 Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Offered

13.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Circassia Pharmaceuticals Plc. Main Business Overview

13.3.5 Circassia Pharmaceuticals Plc. Latest Developments

13.4 AstraZeneca Plc.

13.4.1 AstraZeneca Plc. Company Information

13.4.2 AstraZeneca Plc. Pulmonary Drugs Product Offered

13.4.3 AstraZeneca Plc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca Plc. Main Business Overview

13.4.5 AstraZeneca Plc. Latest Developments

13.5 GlaxoSmithKline Plc.

13.5.1 GlaxoSmithKline Plc. Company Information

13.5.2 GlaxoSmithKline Plc. Pulmonary Drugs Product Offered

13.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc. Main Business Overview

13.5.5 GlaxoSmithKline Plc. Latest Developments

13.6 Mallinckrodt Pharmaceuticals Plc.

13.6.1 Mallinckrodt Pharmaceuticals Plc. Company Information

13.6.2 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Offered

13.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Mallinckrodt Pharmaceuticals Plc. Main Business Overview

13.6.5 Mallinckrodt Pharmaceuticals Plc. Latest Developments

13.7 Cheisi Farmaceutici S.p.A

13.7.1 Cheisi Farmaceutici S.p.A Company Information

13.7.2 Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Offered

13.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cheisi Farmaceutici S.p.A Main Business Overview

13.7.5 Cheisi Farmaceutici S.p.A Latest Developments

13.8 Zambon Company S.p.A

13.8.1 Zambon Company S.p.A Company Information

13.8.2 Zambon Company S.p.A Pulmonary Drugs Product Offered

13.8.3 Zambon Company S.p.A Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zambon Company S.p.A Main Business Overview

13.8.5 Zambon Company S.p.A Latest Developments

13.9 Alaxia SAS

13.9.1 Alaxia SAS Company Information

13.9.2 Alaxia SAS Pulmonary Drugs Product Offered

13.9.3 Alaxia SAS Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Alaxia SAS Main Business Overview

13.9.5 Alaxia SAS Latest Developments

13.10 Merck Sharp & Dohme Limited

13.10.1 Merck Sharp & Dohme Limited Company Information

13.10.2 Merck Sharp & Dohme Limited Pulmonary Drugs Product Offered

13.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Merck Sharp & Dohme Limited Main Business Overview

13.10.5 Merck Sharp & Dohme Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Pulmonary Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pulmonary Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inhaled Corticosteroids

Table 4. Major Players of Long Acting Beta-2 Agonists

Table 5. Major Players of Antihistamines

Table 6. Major Players of Vasodilators

Table 7. Major Players of Others

Table 8. Global Pulmonary Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Pulmonary Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Pulmonary Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Pulmonary Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Pulmonary Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Pulmonary Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Pulmonary Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Pulmonary Drugs Revenue by Application (2017-2022)

Table 16. Global Pulmonary Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Pulmonary Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Pulmonary Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Pulmonary Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Pulmonary Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Pulmonary Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Pulmonary Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Pulmonary Drugs Producing Area Distribution and Sales Area

Table 24. Players Pulmonary Drugs Products Offered

Table 25. Pulmonary Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Pulmonary Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Pulmonary Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Pulmonary Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Pulmonary Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Pulmonary Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Pulmonary Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Pulmonary Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Pulmonary Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Pulmonary Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Pulmonary Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Pulmonary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Pulmonary Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Pulmonary Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Pulmonary Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Pulmonary Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Pulmonary Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Pulmonary Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Pulmonary Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Pulmonary Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Pulmonary Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Pulmonary Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Pulmonary Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Pulmonary Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Pulmonary Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Pulmonary Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Pulmonary Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Pulmonary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Pulmonary Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Pulmonary Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Pulmonary Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Pulmonary Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Pulmonary Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Pulmonary Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Pulmonary Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Pulmonary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Pulmonary Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Pulmonary Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Pulmonary Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Pulmonary Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Pulmonary Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Pulmonary Drugs

Table 69. Key Market Challenges & Risks of Pulmonary Drugs

Table 70. Key Industry Trends of Pulmonary Drugs

Table 71. Pulmonary Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Pulmonary Drugs Distributors List

Table 74. Pulmonary Drugs Customer List

Table 75. Global Pulmonary Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Pulmonary Drugs Sales Market Forecast by Region

Table 77. Global Pulmonary Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Pulmonary Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Pulmonary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Pulmonary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Pulmonary Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Pulmonary Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Pulmonary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Pulmonary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Pulmonary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Pulmonary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Pulmonary Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Pulmonary Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Pulmonary Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Pulmonary Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Pulmonary Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Pulmonary Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Pulmonary Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Pulmonary Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Sanofi SA Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Sanofi SA Pulmonary Drugs Product Offered

Table 97. Sanofi SA Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Sanofi SA Main Business

Table 99. Sanofi SA Latest Developments

Table 100. Meda Pharmaceuticals Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Meda Pharmaceuticals Pulmonary Drugs Product Offered

Table 102. Meda Pharmaceuticals Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Meda Pharmaceuticals Main Business

Table 104. Meda Pharmaceuticals Latest Developments

Table 105. Circassia Pharmaceuticals Plc. Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Offered

Table 107. Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Circassia Pharmaceuticals Plc. Main Business

Table 109. Circassia Pharmaceuticals Plc. Latest Developments

Table 110. AstraZeneca Plc. Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. AstraZeneca Plc. Pulmonary Drugs Product Offered

Table 112. AstraZeneca Plc. Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. AstraZeneca Plc. Main Business

Table 114. AstraZeneca Plc. Latest Developments

Table 115. GlaxoSmithKline Plc. Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. GlaxoSmithKline Plc. Pulmonary Drugs Product Offered

Table 117. GlaxoSmithKline Plc. Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. GlaxoSmithKline Plc. Main Business

Table 119. GlaxoSmithKline Plc. Latest Developments

Table 120. Mallinckrodt Pharmaceuticals Plc. Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Offered

Table 122. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Mallinckrodt Pharmaceuticals Plc. Main Business

Table 124. Mallinckrodt Pharmaceuticals Plc. Latest Developments

Table 125. Cheisi Farmaceutici S.p.A Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Offered

Table 127. Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Cheisi Farmaceutici S.p.A Main Business

Table 129. Cheisi Farmaceutici S.p.A Latest Developments

Table 130. Zambon Company S.p.A Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Zambon Company S.p.A Pulmonary Drugs Product Offered

Table 132. Zambon Company S.p.A Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Zambon Company S.p.A Main Business

Table 134. Zambon Company S.p.A Latest Developments

Table 135. Alaxia SAS Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Alaxia SAS Pulmonary Drugs Product Offered

Table 137. Alaxia SAS Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Alaxia SAS Main Business

Table 139. Alaxia SAS Latest Developments

Table 140. Merck Sharp & Dohme Limited Basic Information, Pulmonary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Merck Sharp & Dohme Limited Pulmonary Drugs Product Offered

Table 142. Merck Sharp & Dohme Limited Pulmonary Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Merck Sharp & Dohme Limited Main Business

Table 144. Merck Sharp & Dohme Limited Latest Developments

List of Figures

Figure 1. Picture of Pulmonary Drugs

Figure 2. Pulmonary Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pulmonary Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pulmonary Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pulmonary Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inhaled Corticosteroids

Figure 10. Product Picture of Long Acting Beta-2 Agonists

Figure 11. Product Picture of Antihistamines

Figure 12. Product Picture of Vasodilators

Figure 13. Product Picture of Others

Figure 14. Global Pulmonary Drugs Sales Market Share by Type in 2021

Figure 15. Global Pulmonary Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Pulmonary Drugs Consumed in Asthma & COPD

Figure 17. Global Pulmonary Drugs Market: Asthma & COPD (2017-2022) & (K Units)

Figure 18. Pulmonary Drugs Consumed in Allergic Rhinitis

Figure 19. Global Pulmonary Drugs Market: Allergic Rhinitis (2017-2022) & (K Units)

Figure 20. Pulmonary Drugs Consumed in Pulmonary Arterial Hypertension

Figure 21. Global Pulmonary Drugs Market: Pulmonary Arterial Hypertension (2017-2022) & (K Units)

Figure 22. Pulmonary Drugs Consumed in Cystic Fibrosis

Figure 23. Global Pulmonary Drugs Market: Cystic Fibrosis (2017-2022) & (K Units)

Figure 24. Pulmonary Drugs Consumed in Others

Figure 25. Global Pulmonary Drugs Market: Others (2017-2022) & (K Units)

Figure 26. Global Pulmonary Drugs Sales Market Share by Application (2017-2022)

Figure 27. Global Pulmonary Drugs Revenue Market Share by Application in 2021

Figure 28. Pulmonary Drugs Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Pulmonary Drugs Revenue Market Share by Company in 2021

Figure 30. Global Pulmonary Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Pulmonary Drugs Revenue Market Share by Geographic Region in 2021

Figure 32. Global Pulmonary Drugs Sales Market Share by Region (2017-2022)

Figure 33. Global Pulmonary Drugs Revenue Market Share by Country/Region in 2021

Figure 34. Americas Pulmonary Drugs Sales 2017-2022 (K Units)

Figure 35. Americas Pulmonary Drugs Revenue 2017-2022 ($ Millions)

Figure 36. APAC Pulmonary Drugs Sales 2017-2022 (K Units)

Figure 37. APAC Pulmonary Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Europe Pulmonary Drugs Sales 2017-2022 (K Units)

Figure 39. Europe Pulmonary Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Pulmonary Drugs Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Pulmonary Drugs Revenue 2017-2022 ($ Millions)

Figure 42. Americas Pulmonary Drugs Sales Market Share by Country in 2021

Figure 43. Americas Pulmonary Drugs Revenue Market Share by Country in 2021

Figure 44. United States Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Pulmonary Drugs Sales Market Share by Region in 2021

Figure 49. APAC Pulmonary Drugs Revenue Market Share by Regions in 2021

Figure 50. China Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Pulmonary Drugs Sales Market Share by Country in 2021

Figure 57. Europe Pulmonary Drugs Revenue Market Share by Country in 2021

Figure 58. Germany Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Pulmonary Drugs Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Pulmonary Drugs Revenue Market Share by Country in 2021

Figure 65. Egypt Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Pulmonary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Pulmonary Drugs in 2021

Figure 71. Manufacturing Process Analysis of Pulmonary Drugs

Figure 72. Industry Chain Structure of Pulmonary Drugs

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles